Home > News > PGI research may help lower drug dosage
July 9th, 2007
PGI research may help lower drug dosage
In future, people suffering from tuberculosis (TB), cardiovasucular diseases, hypertension and other chronic diseases may not have to take drugs daily for the rest of their lives. A path breaking pre-clinical research by a team of doctors at the PGI has established a system of sustained drug delivery through nanotechnology.
The system involves encapsulating the drug in nanoparticles taken from synthetic polymers. This ensures that the drug stays in the plasma and the organs for a longer period. Secondly, since the frequency of taking drugs comes down, lesser drugs are used.
Untangling DNA with a droplet of water, a pipet and a polymer: With the 'rolling droplet technique,' a DNA-injected water droplet rolls like a ball over a platelet, sticking the DNA to the plate surface February 27th, 2015
Graphene shows potential as novel anti-cancer therapeutic strategy: University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells February 26th, 2015
Cutting-edge technology optimizes cancer therapy with nanomedicine drug combinations: UCLA bioengineers develop platform that offers personalized approach to treatment February 24th, 2015
Optical nanoantennas set the stage for a NEMS lab-on-a-chip revolution February 24th, 2015
Scientific breakthrough in rechargeable batteries: Researchers from Singapore and Québec Team Up to Develop Next-Generation Materials to Power Electronic Devices and Electric Vehicles February 28th, 2015
First detailed microscopy evidence of bacteria at the lower size limit of life: Berkeley Lab research provides comprehensive description of ultra-small bacteria February 28th, 2015
Leti to Offer Updates on Silicon Photonics Successes at OFC in LA February 27th, 2015
Moving molecule writes letters: Caging of molecules allows investigation of equilibrium thermodynamics February 27th, 2015